Neuraptive Therapeutics
Louisville, US · Founded 2017
Biotech
Founders & leadership
DJ
David JacksonExecutive Officer, Director
GD
Gino DiSciulloDirector
GP
Greg ParekhDirector
IG
Ivan GergelDirector
RH
Randy HubbellDirector
Reported raises · per SEC filings
Form D private placements$19.5MraisedOct 2022 · 71 investors · Biotechnology
Rule 506(b)$10.2MraisedApr 2019 · 5 investors · Biotechnology
Rule 506(b)$100KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)$25KraisedAug 2017 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.